Monopar Therapeutics (MNPR) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 22, 2026, at 10:00 A.M. Central Time in Wilmette, IL.

• Shareholders can vote online, by mail, or in person, with materials available electronically or by request.

Voting matters and shareholder proposals

• Election of six directors: Christopher M. Starr, Chandler D. Robinson, Raymond W. Anderson, Kim R. Tsuchimoto, Lavina Talukdar, and Nicole Sweeny.

• Advisory vote to approve named executive officer compensation.

• Approval of the 2026 Stock Incentive Plan.

• Ratification of BPM LLP as independent registered public accounting firm for 2026.

• Proxies authorized to vote on other matters arising at the meeting.

Board of directors and corporate governance

• Board recommends voting in favor of all proposals and director nominees.